/daily ·11 SEPT 2026 ·FRIDAY ·2 MIN READ ·5 STORIES

The Senolytic Score

A Phase IIa trial reports biological age reversal on six proteomic clocks, creatine builds muscle in older adults who did not exercise, and a novel senolytic target arrives with better selectivity.

01 / The Day

FRIDAY 11 SEPT 2026, ranked

Phase IIa Trial Shows 3-6 Year Biological Age Reduction on Six Proteomic Clocks

A Phase IIa trial of rentosertib — a senomorphic compound tested in idiopathic pulmonary fibrosis patients — found that across six independently developed proteomic aging clocks, treated patients showed statistically significant reductions in predicted biological age compared to placebo, with peak effects of 3-4 years at the 30 mg twice-daily dose.

All six proteomic clocks moved in the same direction — cross-clock concordance at this level is unusual for any single intervention
Serum profiling confirmed downregulation of multiple SASP components including MMP10, MMP13, and SPP1
Trial was conducted in IPF patients, not healthy adults; generalisability to other populations is not established

Why it mattersCross-clock biological age reversal in a placebo-controlled trial is the strongest clinical signal the senolytic/senomorphic field has produced to date, if the finding holds in larger trials.

01 nature.com↗

Creatine Improves Muscle Mass and Cognition in Older Adults Without Exercise

A clinical study found that creatine monohydrate supplementation in older adults produced measurable improvements in lean muscle mass and cognitive assessments over 16 weeks without requiring concurrent resistance training — an effect previously attributed to the combination of creatine with exercise.

Muscle mass improvement was statistically significant vs placebo; absolute effect size was approximately 1-1.5 kg lean mass over 16 weeks
Cognitive improvements were most pronounced on processing speed and working memory tasks
Creatine dose was 5g per day; the study did not test higher doses or longer durations

Why it mattersA supplementation effect that does not require exercise to activate is directly relevant to frailer older populations most in need of muscle preservation and cognitive interventions.

02 psypost.org↗

PGAM1-CHK1 Inhibition Identified as New Selective Senolytic Target

Researchers demonstrated that inhibiting the interaction between the metabolic enzyme PGAM1 and checkpoint kinase CHK1 selectively triggers apoptosis in senescent cells while sparing normal proliferating cells — a mechanistic distinction that addresses the main selectivity concern with first-generation senolytics.

Selectivity for senescent cells over proliferating cells was demonstrated in cell culture; animal models are the next experimental step
PGAM1 is a glycolytic enzyme, suggesting senescent cells have a metabolic dependency that can be exploited for targeted clearance
The CHK1 connection places this in the DNA damage response pathway, consistent with the broader understanding of senescence induction

Why it mattersSenolytics that selectively destroy senescent cells while leaving healthy tissue intact have been a central mechanistic goal since the field began; a metabolic handle with demonstrated selectivity is a meaningful step.

03 fightaging.org↗

Disrupted Calcium Handling in Muscle Cells Linked to Age-Related Muscle Loss

A study found that impaired calcium release and reuptake in muscle cells — the process coordinating muscle contraction — contributes to progressive age-related muscle loss, identifying a molecular target for sarcopenia distinct from the protein synthesis pathways that existing interventions target.

The calcium-handling defect was observed in both muscle cells from aged animals and in experimentally aged cultured cells
Restoring calcium cycling in aged muscle cells partially rescued contractile function in vitro
This mechanism operates independently of the mTOR pathway targeted by most current sarcopenia research programmes

Why it mattersSarcopenia has no approved pharmacological treatment; a mechanistically distinct driver opens a new drug development direction for a condition affecting hundreds of millions of older adults.

04 lifespan.io↗

Childhood Platinum Chemotherapy Produces Liver Mutations Linked to Premature Aging

A study of cancer survivors who received cisplatin or carboplatin in childhood found their livers carry a higher burden of somatic mutations associated with aging — specifically the COSMIC signatures SBS31 and SBS35 — compared to age-matched controls, suggesting chemotherapy-accelerated biological aging in the liver.

Mutation burden was highest in patients who received platinum agents before age 10, during a period of rapid liver cell proliferation
Elevated somatic mutation burden in the liver is an established risk factor for hepatocellular carcinoma in aging adults
Findings support long-term liver monitoring protocols for childhood platinum chemotherapy survivors as they reach middle age

Why it mattersTens of thousands of childhood cancer survivors are now adults in their 30s and 40s; understanding the long-term biological cost of curative treatment shapes both monitoring guidelines and future treatment decisions.

05 statnews.com↗

Be subscriber #013 the weekly ten, every friday by email · no spam · unsubscribe anytime

Past days

The Daily Archive

/MON 14 SEPTThe SASP Dial /FRI 11 SEPTThe Senolytic Score /WED 09 SEPTWhat the Studies Found This Week /MON 07 SEPTAge is personal; centenarians deliver; Alzheimer's gets a blood test /FRI 04 SEPTLongevity — Friday 4 September /WED 02 SEPTWednesday Tissue Atlas /MON 31 AUGCellular Mechanisms, Measured /FRI 28 AUGExercise in a Dish, Inflammaging Mapped, and a Million-Person Gene Hunt /WED 26 AUGCascades, Clocks, and the Cheapest Dementia Intervention /MON 24 AUGLongevity — Mon 24 Aug 2026 /FRI 21 AUGThe immune systems of the very old /WED 19 AUGExercise in a pill, a gut microbiome review, and the senolytic biomarker gap /MON 17 AUGBrains, Exomes and a Cocktail /FRI 14 AUGWhat the Clocks Are Actually Measuring /WED 12 AUGInflammation, isolation, and the stem cells in your gut /MON 10 AUG350 papers on protein, 20 clinical trials, and a ceiling made of DNA /FRI 07 AUGFirst mRNA flu vaccine; tau finds a second way to harm /WED 05 AUGSenolytics, centenarian microbes, and a protein that poisons aging brains /MON 03 AUGProtein, lifespan ceilings, and uneven clocks /FRI 31 JULBlood proteins predict liver disease 16 years early /WED 29 JULWednesday, 29 July — Clocks, guts, heat